(Q43906380)

English

Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

Taizo Nakazato

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Akitane Akiyama

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

930

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

134-142

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

In vitro measurement of dopamine concentration with carbon fiber electrode

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Measurement of 3-methoxytyramine by in vivo voltammetry: evidence for differences in central dopamine function in BALB/c and CBA mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Multi-center study of Parkinson mortality with early versus later dopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Sensitivity studies of L‐dopa metabolites in reserpinized rats and their clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Reversal of the reserpine syndrome with L‐dopa metabolites in reserpinized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Asymmetric action of intraventricular monoamine neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Psychiatric Side Effects of Levodopa in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

L-DOPA induces concentration-dependent facilitation and inhibition of presynaptic acetylcholine release in the guinea-pig submucous plexus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Duration of catalepsy correlates with increased intrastriatal sulpiride.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Dopamine- and dopa-immunoreactive neurons in the cat forebrain with reference to tyrosine hydroxylase-immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Pathogenesis of dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Non-effective dose of exogenously applied L-dopa itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities of conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

In vivo voltammetric study of 6-hydroxydopamine-induced neuronal degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Effect of exogenous L-dopa on behavior in the rat: an in vivo voltammetric study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

In vivo electrochemical measurement of the long-lasting release of dopamine and serotonin induced by intrastriatal kainic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Pharmacokinetics of Levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Does acute L-DOPA increase active release of dopamine from dopaminergic neurons?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

The mode of neuromuscular block caused by acetylcholine, nicotine, decamethonium and succinylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Effect of 3,4-dihydroxyphenylacetic acid on catecholamines and serotonin in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Simultaneous measurement of acetylcholine and monoamines by two serial on-line microdialysis systems: effects of methamphetamine on neurotransmitters release from the striatum of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Striatal 3-methoxytyramine as an index of dopamine release: Effects of electrical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902238-2

7 January 2021

Identifiers

10.1016/S0006-8993(02)02238-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43906380&oldid=2104304746"